Conditioning Side Effects in the Stem Cell Transplant
Learning Objectives
Prepare House Officers for potential complications they might encounter when cross-covering the Stem Cell Transplant Unit
Understand the potential neurotoxicity and initial management for Busulfan & Cyclosporine
Know the general fluid management for Cyclophosphamide administration & the potential for iatrogenic hyponatremia
Understand the common side effects of serotherapy
Author(s)
Steven Margossian, MD, PhD
Senior Medical Director | Nuvalent
Assistant Professor of Pediatrics | Harvard Medical School
Traci Wolbrink, MD, MPH
Co-Director, OPENPediatrics; Co-Director, Center for Educational Excellence and Innovation; Program Director, Pediatric Critical Care Medicine Fellowship; Senior Associate in Critical Care Medicine | Boston Children’s Hospital
Associate Professor of Anaesthesia | Harvard Medical School
Mollie Grunat
Resident Doctor | Thomas Jefferson University Hospitals
Kristan Scott, MD
Attending Physician, Division of Neonatology | Children's Hospital of Philadelphia.
Katherine R. Schlosser Metitri, MD
Pediatric Critical Care Specialist | Columbia University
Vice President, Operations | NewYork-Presbyterian Morgan Stanley Children’s Hospital
Citation
Margossian S, Grunat MS, Scott K, Wolbrink TA, Schlosser KR. Conditioning Side Effects in Stem Cell Transplant. 4/2018. Online Video. OPENPediatrics. https://learn.openpediatrics.org/learn/course/internal/view/elearning/2863/conditioning-side-effects-in-stem-cell-transplant.